Outcomes of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation

• Shigeo Fuji,
• Atae Utsunomiya,
• Yoshitaka Inoue,
• Takashi Miyagi,
• Satsuki Owatari,
• Yasushi Sawayama,
• Yukiyoshi Moriuchi,
• Ilseung Choi,
• Takero Shindo,
• Shin-ichiro Yoshida,
• Satoshi Yamasaki,
• Takuhiro Yamaguchi,
• Takahiro Fukuda

Affiliations

Shigeo Fuji

Department of Hematology, Osaka International Cancer Institute, Tokyo, Japan;Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan

Atae Utsunomiya

Department of Hematology, Imamura General Hospital, Kagoshima, Japan

Yoshitaka Inoue

Department of Hematology, Kumamoto University Hospital, Okinawa, Japan

Takashi Miyagi

Department of Hematology, Heart-Life Hospital, Okinawa, Japan

Satsuki Owatari

Department of Hematology, National Hospital Organization Kagoshima Medical Center, Nagasaki, Japan

Yasushi Sawayama

Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan

Yukiyoshi Moriuchi

Department of Hematology, Sasebo City General Hospital, Nagasaki, Japan

Ilseung Choi

Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan

Takero Shindo

Department of Hematology, Respiratory Medicine and Oncology, Saga University School of Medicine, Fukuoka, Japan

Shin-ichiro Yoshida

Department of Hematology, National Hospital Organization Nagasaki Medical Center, Fukuoka, Japan

Satoshi Yamasaki

Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan

Takuhiro Yamaguchi

Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan

Takahiro Fukuda

Department of Hematology, Osaka International Cancer Institute, Tokyo, Japan